https://www.selleckchem.com/pr....oducts/leukadherin-1
41, 95% CI 1.2-1.66, p less then 0.001). Other factors significantly associated with pCR included insurance, facility type, tumor characteristics, clinical stage, and time between radiation and surgery. CONCLUSIONS This is the first investigation demonstrating that standard dose neoadjuvant radiation for rectal cancer was associated with a lower likelihood of pCR compared with standard dose with boost. Past studies demonstrate that rectal cancer patient survival is strongly correlated with pCR. Prospective trials should focus on
Like
Comment
Share
